Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
University of Washington · with National Institute of Nursing Research (NINR) · NCT06593353
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–110 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 4186
- US sites recruiting
- 1
- Study start
- November 21, 2024
- Record last updated
- May 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study evaluates the effectiveness of a health systems strategy (the Systems Analysis and Improvement Approach - SAIA) that packages systems engineering tools (including cascade analysis, flow mapping, and continuous quality improvement) to optimize the management of opioid use disorder (MOUD) care cascade and improve linkages between jails and clinical referral sites.
The investigators will
- study the effectiveness of SAIA on MOUD care cascade quality and continuity for patients receiving care in jail and exiting to referral clinics
- explore determinants of adoption, implementation, and sustainment of SAIA-MOUD across implementation clinics, and
- estimate the cost and cost-effectiveness of SAIA-MOUD
Being studied: Systems Analysis and Improvement Approach (SAIA)
Conditions: Opioid Use Disorder; Opioid Use Disorders
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Implementation Outcomes (consented)
Group 1:
- clinic staff/providers at study clinics (JHS, OBOT, Pathways, Sound)
- age 18+
Group 2:
- current patients at SAIA clinic in the community (OBOT, Pathways, Sound) with jail involvement in the last 12 months
- age 18+
Clinical Outcomes (de-identified data, non consented)
Group 3:
- receive MOUD treatment while incarcerated in King County Jails (WA).
- age 18+
- on Medicaid
- released to community
Exclusion Criteria
Group 1 \& 2:
- do not consent
Group 3:
- not on Medicaid
Recruiting US locations
University of Washington
Seattle, WA 98104
Site contact: Sarah Gimbel, PhD, MPH, BSN · 206 291 4223 · sgimbel@uw.edu
Study contacts (from the official record)
- Sarah Odell Gimbel-Sherr · 206 291 4223 · sgimbel@uw.edu
- Emily Callen · 5182572197 · ejcallen@uw.edu
Similar studies in Washington
All healthy volunteers studies in Washington →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Seattle, WA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
GlaxoSmithKline
- Location
- Seattle, WA + 2 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
GlaxoSmithKline
- Location
- Seattle, WA + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Vega Therapeutics, Inc
- Location
- Seattle, WA + 9 other US sites
- Eligibility basics
- Ages 12–60